HighTower Advisors
CDMO

HighTower Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

HighTower Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,861
Closed -$171K – 4110
2024
Q4 		$171K Buy
13,861
+2,620
+23% +$30K ﹤0.01% 3244
2024
Q3 		$127K Hold
11,241
– – ﹤0.01% 3255
2024
Q2 		$79K Hold
11,241
– – ﹤0.01% 3252
2024
Q1 		$74K Buy
+11,241
New +$77.3K ﹤0.01% 3208

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HighTower Advisors's CDMO Position: Q1 2025 in Review

HighTower Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 13,861 shares — an estimated $171K sold.

HighTower Advisors first reported a position in CDMO in Q1 2024 and held it in 4 quarters. The position peaked at $171K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • HighTower Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 13,861 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $171K.
  • HighTower Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • HighTower Advisors's Avid Bioservices, Inc. Common Stock position peaked at $171K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.